These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 10052044)

  • 1. [Treatment of CMV retinitis with intravitreal foscarnet].
    Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
    J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal foscarnet for cytomegalovirus retinitis in patients with AIDS.
    Ausayakhun S; Watananikorn S; Ngamtiphakorn S; Prasitsilp J
    J Med Assoc Thai; 2005 Jan; 88(1):103-7. PubMed ID: 15960227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical localization of ganciclovir in the human retina.
    Park SS; Girard B; Font RL; Hauw JJ; Young LH
    Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
    Desatnik HR; Foster RE; Lowder CY
    Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-dose intravitreal ganciclovir in CMV retinitis].
    Cochereau I; Diraison MC; Mousalatti H; Bouyer I; Ren L; Guvenisik N; Hoang-Xuan T
    J Fr Ophtalmol; 2000 Feb; 23(2):123-6. PubMed ID: 10705113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
    Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
    Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
    Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high-dose, alternate-week intravitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapy.
    Yutthitham K; Ruamviboonsuk P
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S63-8. PubMed ID: 16681054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
    Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
    Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
    Duker JS; Robinson M; Anand R; Ashton P
    Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cytomegalovirus retinitis in acquired immunodeficiency syndrome with intravitreal ganciclovir implant.
    Tayanithi P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S142-7. PubMed ID: 11529327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravitreal ganciclovir in cytomegalovirus retinitis in AIDS].
    Olea JL; Salvat M; Mateos JM; Vila J; Villalonga C; Riera M
    Rev Clin Esp; 1996 Apr; 196(4):208-12. PubMed ID: 8701057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen.
    Teoh SC; Ou X; Lim TH
    Ophthalmology; 2012 Mar; 119(3):588-95. PubMed ID: 22137552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.